JP

Justin Miranda Pharmd

Medical Science Liaison - Hematology at MorphoSys

Justin Miranda, PharmD, MBA has a diverse work experience in the pharmaceutical industry. Justin has worked as a Medical Science Liaison in various companies, including MorphoSys, Coherus BioSciences, TG Therapeutics, Inc., and Sanofi. In these roles, Justin has established peer-peer relationships with physicians at major academic institutions and community clinics, serving as a scientific peer, medical resource, and expert for internal colleagues. Justin has delivered presentations on scientific medical updates, maximizing acceptance and ensuring proper utilization of oncology and hematology products. Justin has also traveled extensively to develop professional relationships with Key Opinion Leaders and clinical investigators, providing valuable resources and technical support. Prior to their MSL roles, Justin worked as a BMT-Hematology Clinical Pharmacist at UT Southwestern Medical Center, where they trained and educated staff pharmacists on hematology-oncology products and performed chemotherapy interventions. Justin also has experience as a Clinical Staff Pharmacist in oncology at Covenant Health, where they educated patients and family members on chemotherapy and managed daily operations. Justin's extensive experience in the pharmaceutical industry, along with their scientific knowledge and networking skills, make him a valuable asset in the field.

Justin Miranda completed their formal education with a Bachelor's degree in Biology, General from Texas Tech University, which took place from 2004 to 2008. Justin then pursued a Doctor of Pharmacy degree at Texas Tech University Health Sciences Center from 2009 to 2014. Finally, to further enhance their qualifications, Justin pursued a Master of Business Administration (MBA) in Business Administration and Management, General from the Texas Tech University - Rawls College of Business, which they completed from 2014 to 2016.

Links

Timeline

  • Medical Science Liaison - Hematology

    July, 2023 - present

View in org chart